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Conclusion: Our results confirm the validity of PCXMC with 
rotational module also for particular geometrical conditions; 
patient dose can be evaluated based on patient equivalent 
diameter.  
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Purpose or Objective: Hodgkin's lymphoma (HL) is one of the 
most curable types of cancer. Most HL patients are young 
(average age of 32 years); long-term side effects of the 
treatment are becoming increasingly important. Infertility 
after treatment could have a high psychosocial burden for 
young patients. More, HL is one of the most common 
malignancies diagnosed during pregnancy. The aim of the 
present study is to measure dose to ovaries and uterus, 
during supra-diaphragmatic radiotherapy performed with 
different techniques (3DRT, IMRT, VMAT and helical IMRT- 
Tomotherapy®). 
 
Material and Methods: Dose measurements were performed 
using the plans of four different female patients, in 
reproductive age. The patients have been treated with 
chemotherapy and mediastinum irradiation (isocenter dose 
30 Gy). An adult anthropomorphic Alderson Rando phantom 
(Rando phantom) was utilized for woman simulation. For 
each patient the Rando phantom TC-scan was matched with 
the PET/CT. Doing it, an approximate patient specific 
isocenter position on the Rando phantom and a relative 
position of ovaries and uterus in terms of phantom slices 
were identified. Treatment planning images and diagnostic 
whole body PET/CT were fused by means of Velocity AI 3.0 
®. Calcium fluoride thermoluminescent dosimeters, TLD-100, 
were used for dose measurements, 5 TLDs were used for 
every measurement. Patient’s treatment was simulated in 4 
different techniques: 3DRT, IMRT, VMAT and helical IMRT- 
Tomotherapy®. To compare the results paired T student test 
was used. 
 
Results: The equivalent doses to left ovary, right ovary and 
uterus, were respectively 16 mSV (range 5-19), 10 mSV (range 
8-14) and 9 mSV (range 7-12) with 3DRT techniques; 15 mSV 
(range 7-23), 11.5 mSV (range 6-17) and 13 mSV (range 6-18) 
with VMAT; 14 mSV (range 6-23), 14 mSV (range 5-22) and 13 
mSV (range 9-20) with IMRT and 54,5 mSV(range 44-70), 
50mSV (range 40-72) and 56 mSV (range 33-67) with helical 
Tomotherapy®. Helical Tomotherapy® doses were 
significantly higher than the other three (p<10-8 for all three 
tests). IMRT results were significantly higher than VMAT and 
3D (p=0,023 and 0,004 respectively). VMAT and 3D results are 
not statistically different one from each other (p=0,42). 
 
Conclusion: All the techniques give a dose to ovary and 
uterus well below 100 mSv. This is the dose considered safe 
in terms of deterministic effects on embryo or foetus and 
with a relatively low risk of stochastic effect. Helical 
Tomotherapy® and IMRT give higher gonads dose as 
compared to other techniques. The implications of these data 
may be relevant also for patients in the very early stages of 
their pregnancy. 
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Purpose or Objective: The main interest was to decrease the 
localization CBCT scan dose in lung area since the dose 
deposited by CBCT contributes fully in increasing low dose 
volume in lung which is arguably the main indicator of 
radiotherapy induced pneumonitis and fibrosis. Several 
scanning protocols with decreasing dose were investigated to 
confirm that the localization accuracy is not reduced. 
 
Material and Methods: In this work it was investigated how 
do physical scanning parameters - voltage, current and time - 
affect the automatic image registration of the localization 
CBCT using XVI 4.5 system from Elekta. A Cathphan 504 
phantom was used for image quality measurements and an 
anthropomorphic phantom PBU-50 was used to verify 
localization accuracy. 21 scanning protocols with decreasing 
dose and two different automatic registration algorithms 
(Grey value and Bone) were analysed in lung area. Deliberate 
shifts with different size and direction were introduced. 
Image quality of acquired scans was analysed using modular 
transfer function (MTF), uniformity and low contrast 
visibility. Relative scan dose was measured with centered 
Farmer chamber. 
 
 
 
Results: It was found that CBCT system is rather insensitive 
to the size (max 20 mm) and direction of the deliberate shift 
of the phantom. Precision of the correction shifts were within 
0,5 mm that is in the limit of estimated uncertainty. It was 
observed that the MTF was insensitive to physical scanning 
parameters and much more dependant on image 
reconstruction protocol parameters. Uniformity improved and 
low contrast visibility decreased while lowering dose of 
scanning protocol. The CBCT system under investigation 
showed excellent precision for positioning the phantom even 
while dose of scanning protocol was reduced ~90%. On the 
other hand – low contrast visibility decreased and would most 
likely limit the amount of dose redaction to acceptable level 
that is still to be determined. 
 
Conclusion: This work showed that CBCT is a very accurate 
localization method even in conditions where scanning dose 
was decreased to ~10% of initial dose. It is necessary to 
further assess the suitability of new low dose protocols 
qualitatively to develop acceptable clinical scanning 
protocols as well as to investigate possibility to improve 
reconstruction protocols. 
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Purpose or Objective: To construct a data warehouse of 
radiotherapy imaging performance data by automatically 
extracting CT and CBCT acquisition and dose information 
from the hospital PACS and ARIA oncology management 
